AMETEK Inc.: Q1 FY2026 earnings call
What management said about Q1 FY2026, from the documents filed with the SEC on 30 April 2026: press release. Guidance figures: 3 raised, 3 new. The quarter’s numbers.
Key takeaways
- Sales rose 11% to $1.93 billion: Net sales were $1,928.4 million against $1,732.0 million a year earlier. Management attributed earnings growth to organic sales growth and recent acquisitions. Source
- Adjusted EPS rose 13% to $1.97: GAAP diluted EPS was a record $1.74, against $1.52. Adjusted diluted EPS was $1.97, against $1.75, after adding back $0.23 of after-tax amortization and integration costs. Source
- EMG operating income up 33%: EMG operating income rose 33% to a record $170.8 million, from $128.7 million. Operating margin was 25.7%, up 380 basis points on the prior year. Source
- Record orders up 23%: Orders rose 23% in the quarter to a record, and the company ended the quarter with a record backlog. Management described end-market demand as broad based. Source
- Full-year sales guidance raised: Full-year 2026 sales are now expected to be up high single digits compared with 2025, up from mid to high single digits previously. Source
- Full-year adjusted EPS guidance raised: Adjusted EPS range is $7.94 to $8.14, up 7% to 10% on 2025, from $7.87 to $8.07 previously. The GAAP EPS forecast moved to $7.03 to $7.23. Source
- Second-quarter guidance issued: Second-quarter 2026 sales are expected up high single digits, and adjusted EPS is anticipated at $1.96 to $2.00, up 10% to 12% on the second quarter of 2025. Source
“AMETEK had an excellent start to the year. Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to double-digit earnings growth, record EBITDA and robust core margin expansion of 160 basis points,”
David A. Zapico, AMETEK Chairman and Chief Executive Officer
Guidance
| Area | Period | Figure | Against last quarter |
|---|---|---|---|
| Sales Source | Full year 2026 | up high single digits compared to 2025 | Raised from up mid to high single digits compared to 2025 |
| Adjusted diluted EPS Source | Full year 2026 | $7.94 to $8.14, up 7% to 10% over 2025 | Raised from $7.87 to $8.07 |
| GAAP diluted EPS Source | Full year 2026 | $7.03 to $7.23 | Raised from $6.96 to $7.16 |
| Sales Source | Second quarter 2026 | up high single digits compared to the second quarter of 2025 | New |
| Adjusted diluted EPS Source | Second quarter 2026 | $1.96 to $2.00, up 10% to 12% compared to the second quarter of 2025 | New |
| GAAP diluted EPS Source | Second quarter 2026 | $1.73 to $1.77 | New |
What changed from last quarter
- Guidance raised: Full-year 2026 sales guidance moved from mid to high single digits growth to high single digits growth. Source
- Guidance raised: Full-year 2026 adjusted EPS range raised to $7.94 to $8.14 from $7.87 to $8.07. Source
- Guidance raised: Full-year 2026 GAAP diluted EPS forecast raised to $7.03 to $7.23 from $6.96 to $7.16. Source
- New guidance: Second-quarter 2026 sales and adjusted EPS guidance added; the prior release gave only first-quarter guidance. Source
Results and growth drivers
- Sales rose 11% to $1.93 billion: Net sales were $1,928.4 million against $1,732.0 million a year earlier. Management attributed earnings growth to organic sales growth and recent acquisitions. Source
- Adjusted EPS rose 13% to $1.97: GAAP diluted EPS was a record $1.74, against $1.52. Adjusted diluted EPS was $1.97, against $1.75, after adding back $0.23 of after-tax amortization and integration costs. Source
- Operating income and margin rose: GAAP operating income was $514.9 million. Adjusted operating income rose 14% to $516.6 million, and the release gives operating margin of 26.8%, up 50 basis points. Source
- Record EBITDA and core margin gain: Management cited double-digit earnings growth, record EBITDA and core margin expansion of 160 basis points, from organic growth, acquisitions and operating performance. Source
Segment results
- EIG sales up 11% to $1.26 billion: Electronic Instruments sales were $1,264.5 million, against $1,143.7 million, with organic growth and recent acquisitions contributing. Management described EIG orders growth as broad based. Source
- EIG adjusted operating income up 6%: EIG segment operating income was $373.9 million GAAP and $375.6 million adjusted. Adjusted segment margin was 31.4%, up 40 basis points, and GAAP segment margin was 29.6%. Source
- EMG sales a record $663.9 million: Electromechanical sales were $663.9 million, up 13% from $588.3 million. Management cited robust, broad-based organic sales growth in the segment. Source
- EMG operating income up 33%: EMG operating income rose 33% to a record $170.8 million, from $128.7 million. Operating margin was 25.7%, up 380 basis points on the prior year. Source
“Additionally, end market demand remains strong and broad based, with record orders up 23% in the quarter resulting in a record backlog.”
David A. Zapico, AMETEK Chairman and Chief Executive Officer
Costs and margins
- Cost of sales and SG&A rose: Cost of sales was $1,210.9 million, against $1,107.0 million. Selling, general and administrative expense was $202.6 million, against $170.2 million. Total operating expenses were $1,413.5 million. Source
- Acquisition integration costs in cost of sales: Acquisition-related costs were $1.6 million, recorded as integration costs in cost of sales. The reconciliation adds $0.01 to diluted EPS for these costs. Source
- Adjusted operating margin 27.9% versus 26.3%: The reconciliation table shows GAAP operating margin of 26.7% and adjusted margin of 27.9%, against 26.3% a year earlier. It adds 0.1 points of acquisition costs and 1.1 points of acquisition and currency dilution. Source
Demand and order book
- Record orders up 23%: Orders rose 23% in the quarter to a record, and the company ended the quarter with a record backlog. Management described end-market demand as broad based. Source
- Organic growth broad across EMG: Management said EMG's organic sales growth was robust and broad based, resulting in profit growth and sizeable margin expansion in the quarter. Source
Guidance for 2026 and Q2
- Full-year sales guidance raised: Full-year 2026 sales are now expected to be up high single digits compared with 2025, up from mid to high single digits previously. Source
- Full-year adjusted EPS guidance raised: Adjusted EPS range is $7.94 to $8.14, up 7% to 10% on 2025, from $7.87 to $8.07 previously. The GAAP EPS forecast moved to $7.03 to $7.23. Source
- Second-quarter guidance issued: Second-quarter 2026 sales are expected up high single digits, and adjusted EPS is anticipated at $1.96 to $2.00, up 10% to 12% on the second quarter of 2025. Source
Capital, cash and balance sheet
- Debt and cash position: Short-term borrowings and current debt were $1,114.9 million, against $1,209.0 million at December 31. Cash rose to $481.3 million from $458.0 million. Source
- Dividends and diluted shares: Dividends per share were $0.34, against $0.31 a year earlier. Diluted weighted average shares were 229.8 million, against 231.5 million. Source
- Receivables and inventories rose: Receivables were $1,154.0 million at March 31, against $1,119.3 million at December 31. Inventories were $1,143.4 million, against $1,106.4 million. Source
Strategy and acquisition capacity
- Growth Model and niche markets: Management said AMETEK remains positioned on its record backlog, momentum across its markets and the AMETEK Growth Model, which integrates four growth strategies. Source
- Acquisition capital available: Management said the balance sheet and cash flows provide meaningful capital to deploy on strategic acquisitions. Goodwill rose to $7,266.4 million from $7,170.8 million at year-end. Source
Coming up, as management said on 30 April 2026
- Acquisition capital available: Management said the balance sheet and cash flows give the company capital to deploy on strategic acquisitions. The release names no specific transaction. Source
- Second-quarter guidance set: Management expects second-quarter 2026 sales up high single digits compared with the second quarter of 2025. Source
Figures management reported
Earlier plans management reported on
- Not stated: The company states an objective of double-digit percentage EPS growth over the business cycle and a superior return on total capital. Source
- Not stated: The prior release guided first-quarter sales up about 10%. The current release reports first-quarter sales up 11% and adjusted EPS of $1.97, without stating a comparison to that guidance.
Other quarters
Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.